eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 68
Original paper

Comparison of clinicopathological features in incidental and nonincidental papillary thyroid carcinomas in 308 patients

Nuray Can, Filiz Ozyilmaz, Mehmet Celik, Atakan Y. Sezer, Necdet Sut, Ebru Tastekin, Semra Ayturk, Funda Ustun, Buket Y. Bulbul, Sibel Guldiken

Pol J Pathol 2017; 68 (3): 197-209
Online publish date: 2017/11/30
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Incidental papillary thyroid carcinomas (IPTCs) consist of a significant portion of increasing incidence in papillary thyroid carcinomas. This study investigated the clinicopathological features of IPTCs from different perspectives and by comparing nonincidental PTCs (NIPTCs) in patients who underwent total thyroidectomy and lymph node dissection. Basic results were as follows. IPTC was present in 27.9% of 308 patients. IPTCs were significantly accompanied by lymphocytic thyroiditis (LT), particularly, multinodular hyperplasia (MNH). IPTCs were more common in older patients (51.3 years vs. 47.2 years) and in female patients. IPTCs significantly differed from NIPTCs in terms of smaller tumour size, lymphatic vessel invasion (2.6% vs. 97.4%), extrathyroidal extension (4.3% vs. 95.7%), lymph node metastasis (3.6% vs. 96.4%), multifocality (21.2% vs. 78.8%), bilaterality (5.3% vs. 94.7%), and BRAFV600 mutation (6.7% vs. 93.3%). Older age, bilaterality, encapsulation, and radioactive iodine (RAI) were significantly more common in IPTCs > 5 mm than in those ≤ 5 mm. In conclusion, IPTCs are more commonly associated with LT and MNH. IPTCs may have a more favourable prognosis than NIPTCs, and tumour size > 5 mm may predict bilaterality and need for RAI. Nevertheless, the patient-based clinical approach in IPTCs may have benefits in the management of IPTCs.

incidental papillary thyroid carcinoma, nonincidental papillary thyroid carcinoma, clinicopathological feature

Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014; 140: 317-322.
Chow SM, Law SC, Au SK, et al. Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960-2000. Clin Oncol (R Coll Radiol) 2003; 15: 329-336.
Schoedel KE, Wolfe J, Hodak SP, et al. Significance of what is not sampled: Characteristics of thyroid nonmicrocarcinomas (> 1.0 cm) that were not targeted. Cancer Cytopathol 2015; 123: 678-683.
Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2009; 19: 1159-1165.
Dunki-Jacobs E, Grannan K, McDonough S, Engel AM. Clinically unsuspected papillary microcarcinomas of the thyroid: a common finding with favorable biology? Am J Surg 2012; 203: 140-144.
Morris LG, Tuttle RM, Davies L. Changing Trends in the Incidence of Thyroid Cancer in the United States. JAMA Otolaryngol Head Neck Surg 2016; 142: 709-711.
Costamagna D, Pagano L, Caputo M, et al. Incidental cancer in patients surgically treated for benign thyroid disease. Our experience at a single institution. G Chir. 2013; 34: 21-26.
Lombardi CP, Bellantone R, De Crea C, et al. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg 2010; 34: 1214-1221.
Teixeira GV, Chikota H, Teixeira T, et al. Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration. World J Surg 2012; 36: 69-74.
Nanjappa N, Kumar A, Swain SK, et al. Incidental thyroid carcinoma. Indian J Otolaryngol Head Neck Surg 2013; 65: 37-39.
Vasileiadis I, Karatzas T, Vasileiadis D, et al. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients. Head Neck 2014; 36: 564-570.
Kaliszewski K, Diakowska D, Strutyńska-Karpińska M, et al. Clinical and histopathological characteristics of patients with incidental and nonincidental thyroid cancer. Arch Med Sci 2016; 13: 390-395.
Boucek J, Kastner J, Skrivan J, et al. Occult thyroid carcinoma. Acta Otorhinolaryngol Ital 2009; 29: 296-304.
Lin YS, Wu HY, Yu MC, et al. Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy? Medicine (Baltimore) 2016; 95 (28): e4194.
Farrell E, Heffron C, Murphy M, et al. Impact of lymphocytic thyroiditis on incidence of pathological incidental thyroid carcinoma. Head Neck 2017; 39: 122-127.
Slijepcevic N, Zivaljevic V, Marinkovic J, et al. Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease. BMC Cancer 2015; 15: 330.
Pagni F, Jaconi M, Delitala A, et al. Incidental papillary thyroid carcinoma: diagnostic findings in a series of 287 carcinomas. Endocr Pathol 2014; 25: 288-296.
Gulben K, Berberoglu U, Celen O, Mersin HH. Incidental papillary microcarcinoma of the thyroid – factors affecting lymph node metastasis. Langenbecks Arch Surg 2008; 39: 25-29.
Pelizzo MR, Rubello D, Bernardi C, et al. Thyroid surgical practices shaping thyroid cancer incidence in North-Eastern Italy. Biomed Pharmacother 2014; 68: 39-43.
Haugen BR. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? Cancer 2017; 123: 372-381.
Pezzolla A, Marzaioli R, Lattarulo S, et al. Incidental carcinoma of the thyroid. Int J Surg. 2014; 12 Suppl 1: S98-102.
Muntean V, Domsa I, Zolog A, et al. Incidental papillary thyroid microcarcinoma: is completion surgery required? Chirurgia (Bucur) 2013; 108: 490-497.
Lin JD. Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer. Med Oncol 2010; 27 (2): 510-518.
Mehanna H, Al-Maqbili T, Carter B, et al. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab 2014; 99: 2834-2843.
Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol 2016; 2: 1023-1029.
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
Bradly DP, Reddy V, Prinz RA, Gattuso P. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 2009; 146: 1099-1104.
Barbaro D, Simi U, Meucci G, et al. Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers - are they different diseases? Clin Endocrinol (Oxf) 2005; 63: 577-581.
Bisi H, Fernandes VS, de Camargo RY, et al. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer 1989; 64: 1888-1893.
Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 1985; 56: 531-538.
Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, et al. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 1993; 71: 4022-4029.
Azatcam M. The prevalence of thyroid papillary carcinoma at autopsy. Unpublished doctoral dissertation, Trakya University, Edirne-Turkey 2013. https://tez.yok.gov.tr/UlusalTezMerkezi/tezSorguSonucYeni.jsp#.
Neuhold N, Schultheis A, Hermann M, et al. Incidental papillary microcarcinoma of the thyroid - further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up. Ann Surg Oncol 2011; 18: 3430-3436.
Kaliszewski K, Wojtczak B, Strutynska-Karpinska M, et al. Incidental and non-incidental thyroid microcarcinoma. Oncol Lett 2016; 12: 734-740.
Elliott MS, Gao K, Gupta R, et al. Management of incidental and non-incidental papillary thyroid microcarcinoma. J Laryngol Otol 2013; 127 Suppl 2: S17-23.
Tallini G, de Biase D, Durante C, et al. BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study. Mod Pathol 2015; 28: 1343-1359.
Xu YN, Wang JD. Surgical treatment of incidental and non-incidental papillary thyroid microcarcinoma. G Chir 2010; 31: 205-209.
Wang SF, Zhao WH, Wang WB, et al. Clinical features and prognosis of patients with benign thyroid disease accompanied by an incidental papillary carcinoma. Asian Pac J Cancer Prev 2013; 14: 707-711.
Ergin AB, Saralaya S, Olansky L. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves’ disease and euthyroid goiter, Cleveland Clinic experience. Am J Otolaryngol 2014; 35: 784-790.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe